Skip to main content

Find Clinical Trials

Home
Conditions
Fibrosis

Clinical trial condition

Fibrosis

Explore clinical trials studying Fibrosis. Study availability and eligibility vary by location and protocol.

82 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Fibrosis trial results

Completed

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial

NCT02049307

Conditions: Fibrosis, Inflammation, Pathologic Processes, +1 more
Locations: UCSF San Francisco, California, United States

NIH Clinical Center Bethesda, Maryland, United States

Allina Health Minneapolis, Minnesota, United States

Hennepin County Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

NCT02686762

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Arizona Clinical and Translational Sciences Research Center Tucson, Arizona, United States

Preferred Research Partners, Inc. Little Rock, Arkansas, United States

Fresno Clinical Research Center Freestone, California, United States

View all 103 locations

View Trial Details

Completed

Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis

NCT01268202

Conditions: Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Centre Val d'Aurelle Montpellier, France

Hôpital Européen Georges Pompidou Paris, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Completed

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer

NCT03000764

Conditions: Breast Carcinoma, Breast Diseases, Breast Neoplasms, +7 more
Locations: Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France

View Trial Details

Completed

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants

NCT03142165

Conditions: Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Wcct Global, Llc Cypress, California, United States

View Trial Details

Completed

A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body

NCT03241264

Conditions: Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Not specified

View Trial Details

Completed

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

NCT02958345

Conditions: DNA Virus Infections, Fibrosis, Herpes Zoster, +6 more
Locations: Not specified

View Trial Details

Completed

The Fibrosis-Lymphedema Continuum in Head and Neck Cancer

NCT01187173

Conditions: Behavior, Behavioral Symptoms, Biomarkers, +11 more
Locations: Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

NCT00039871

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin

NCT02630303

Conditions: Cicatrix, Collagen Diseases, Connective Tissue Diseases, +13 more
Locations: Sacramento VA Medical Center Mather, California, United States

View Trial Details